A key Senate committee has included a variety of marijuana and psychedelics-related provisions in a report attached to a pair of spending bills—including calls to allow U.S. Department of Veterans Affairs (VA) doctors to recommend medical cannabis if the federal government reschedules it, exploring the possibility of “reducing opioid use through medical marijuana” and cracking down on illicit grow operations.
For example, the Senate Appropriations Committee report for Military Construction, Veterans Affairs, and Related Agencies (MilConVA) acknowledges that DOJ under former President Joe Biden “concurred” with the Department of Health and Human Services (HHS) recommendation to move marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA).
If rescheduling does happen, “VA should consider issuing guidance allowing VHA doctors and other personnel to discuss, recommend, and facilitate access to medical marijuana in States with state-legal medical marijuana programs to the extent allowable under Federal law,” the report says.
“Medical Marijuana.—The Committee recognizes that the Department of Justice’s Drug Enforcement Agency has concurred with the Department of Health and Human Services’ 2023 recommendation to reschedule cannabis in the Controlled Substances Act from its current placement in Schedule I to the less restrictive Schedule III. Should cannabis be rescheduled to a lower Schedule, VA should consider issuing guidance allowing VHA doctors and other personnel to discuss, recommend, and facilitate access to medical marijuana in States with state-legal medical marijuana programs to the extent allowable under Federal law.”
Another section discusses the potential for cannabis to be used as an alternative treatment option for veterans, urging VA to study “the relationship between treatment programs involving medical marijuana that are approved by States, the access of veterans to such programs, and a reduction in opioid use and abuse among veterans.”
“Reducing Opioid Use Through Medical Marijuana.—The Committee encourages VA to conduct a study on the relationship between treatment programs involving medical marijuana that are approved by States, the access of veterans to such programs, and a reduction in opioid use and abuse among veterans, as data is available to do so. Findings should be provided to the Committee on Appropriations of both Houses of Congress within 1 year of enactment of this act.”
Additionally, a section of the report for MilConVA addresses psychedelics-assisted therapy, noting that members understand “VA and other relevant Federal agencies are undertaking research to evaluate the efficacy of psychedelic-assisted therapies in treating PTSD, major depressive disorder, and other conditions.”
The committee is mandating that VA produce a report to Congress that lays out the status of research into the topic within 180 days of the bill’s enactment, and it’s further directing the agency to “initiate a longitudinal study of veterans participating in such therapies and track outcomes over a period of five years.”
“Psychedelic-Assisted Therapy.—The Committee understands that VA and other relevant Federal agencies are undertaking research to evaluate the efficacy of psychedelic-assisted therapies in treating PTSD, major depressive disorder, and other conditions. The Committee directs the Secretary to submit a report no later than 180 days after enactment of this act to the Committees on Appropriations of both Houses of Congress, on current research and activities related to these therapies, as well as estimated costs of staffing, training, equipment, facility, and other needs to expand use of these treatments. Further, the Department is directed to initiate a longitudinal study of veterans participating in such therapies and track outcomes over a period of 5 years. The study should include: the number of individuals receiving psychedelic-assisted therapies treatment in the last year, the average number of months such individuals served on active duty if available, the distribution of disability ratings of such individuals, the gender distribution of individuals receiving treatment, the number of individuals receiving psychedelic-assisted therapies treatment who suspended participation in such treatment, the average number of treatment sessions and dosages each individual received, the percentage of individuals who experienced a clinically significant reduction in symptoms, and the number of such individuals who experienced a recurrence of their diagnosis after previously receiving this treatment. The Department is directed to report annually on the progress of the study and provide a report to the Committees on Appropriations of both Houses of Congress on outcomes, at the conclusion of the study.”
The report further discusses GI Bill benefits as they related to cannabis, noting that “VA policy determinations have restricted the ability of veterans to access their earned benefits, including GI Bill Benefits.”
A 2022 VA policy advisory stipulated that GI benefits can’t be used for studies that ‘‘have the objective to prepare someone to participate in the cultivation, sale, or distribution of marijuana.’’ And so the committee is directing VA to submit a report with 90 days of enactment “regarding the number of veterans” impacted by the policy.
“Availability of GI Bill Benefits.—The Committee notes that VA policy determinations have restricted the ability of veterans to access their earned benefits, including GI Bill Benefits. In particular, the Committee is aware of the VA Policy Advisory, dated September 2, 2022 and entitled ‘‘State-Legalized Cannabis Training and GI Bill Benefits and Related Addendum,’’ which changed VA policy to no longer allow the use of GI Bill Benefits for courses of study determined to ‘‘have the objective to prepare someone to participate in the cultivation, sale, or distribution of marijuana.’’ The Advisory came despite the offering of such courses in States in which either the recreational or medicinal use of marijuana is legally permissible. The Committee directs VA to submit a report to the Committees on Appropriations of both Houses of Congress no later than 90 days after enactment of this act regarding the number of veterans who this effected.”
In a separate report for the Commerce, Justice, Science, and Related Agencies (CJS) bill, members of the committee included language directing federal agencies to report within 90 days of enactment on the “proliferation of illegal marijuana growing operations associated with foreign nationals.”
“Illegal Growing Operations.—The Committee directs the Department to submit a report, within 90 days of the enactment of this act, assessing the proliferation of illegal marijuana growing operations associated with foreign nationals. The report shall be coordinated among the FBI, DEA, and the Executive Office for United States Attorneys, and shall specifically assess: (1) the extent of illegal growing operations in the United States that are associated with foreign nationals; (2) any connections or links to Chinese transnational criminal organizations and/or the government of the People’s Republic of China; and (3) the Federal resources that can be deployed to support State, local, and Tribal law enforcement efforts. The report may be transmitted through classified channels as necessary and appropriate. The Committee directs the Department, in coordination with Federal law enforcement partners, to fully support State, local, and Tribal law enforcement agencies in their efforts on this matter.”
The Senate Appropriations Committee on Thursday approved the reports as well as the underlying CJS spending bill, which would also maintain protections for states with medical marijuana programs, while omitting a separate proposal included in the House version of the annual appropriations legislation that would prevent the Justice Department from rescheduling cannabis.
Advocates remain concerned, however, about the House language that would restrict DOJ from rescheduling cannabis, but the fact that it was not incorporated into the base bill for the Senate CJS legislation likely diminishes the chances it will ultimately be enacted when the final package is delivered to the president’s desk.
It’s been over six months since DEA Administrative Law Judge (ALJ) John Mulrooney temporarily paused hearings on a proposal to move cannabis to Schedule III. And in a joint report to the judge submitted earlier this month, DEA attorneys and rescheduling proponents said they’re still at an impasse.
The Senate is poised to take an initial step toward confirming President Donald Trump pick to lead DEA on Monday—a development that many cannabis industry observers believe is necessary for the stalled marijuana rescheduling process to proceed.
Notably, while the nominee, Terrance Cole, has said that examining the rescheduling proposal would be “one of my first priorities” if he’s confirmed for the role, he has refused to say what he wants the result to be and has in the past made comments expressing concerns about the health effects of cannabis.
Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
The U.S. Senate voted, 50-47, on July 22 to confirm President Donald Trump’s nomination of Terrance Cole to be the Drug Enforcement Administration (DEA) Administrator.
Cole, who just last year promoted an article claiming cannabis is linked to higher suicide risks for high schoolers, is now in the driver’s seat of the current cannabis rescheduling hearing process that’s been delayed for six months.
Under an order from DEA Chief Administrative Law Judge John J. Mulrooney II, Cole now has sole discretion on whether the hearing process, to debate the merits of a proposed rule to reclassify cannabis to Schedule III under the Controlled Substances Act, should resume.
Cole told U.S. senators during his April confirmation hearing that “it’ll be one of my first priorities” to review where the DEA is in the administrative process to reschedule cannabis upon being confirmed.
However, Cole provided no promises on the Schedule III proposal that was recommended by former President Joe Biden’s U.S. Department of Health and Human Services and published in the Federal Register after former Attorney General Merrick Garland signed off on a notice of proposed rulemaking. Biden’s DEA never backed the proposal.
Cole told members of the Senate Judiciary Committee that he’d give “the matter careful consideration after consulting with appropriate personnel within the Drug Enforcement Administration, familiarizing myself with the current status of the regulatory process, and reviewing all relevant information.”
Here’s how cannabis industry stakeholders reacted to Cole’s July 22 confirmation vote.
Aaron Smith, Co-Founder and CEO of the National Cannabis Industry Association – (In an Open Letter to Terrance Cole)
“Last year, we were honored to be designated by the DEA as one of the select participants in the agency’s public hearing process for the Notice of Proposed Rulemaking (NPRM) to move cannabis from Schedule I to Schedule III under the Controlled Substances Act.
“NCIA continues to believe that marijuana should not be subject to the Controlled Substances Act (CSA); rather, that marijuana products should be regulated under uniform product safety standards that apply equally to all licensed marijuana businesses and protect consumers across the country, developed under new federal law that recognizes that cannabinoid products cannot be governed under the same regulatory pathways that currently apply to pharmaceutical drugs, food, dietary supplements, alcohol, or tobacco.
“However, our association recognizes that the DEA has only been considering the rescheduling of marijuana. We are eager and ready to work with the DEA and Trump administration to, as you said during your confirmation hearing, ‘listen to the experts’ and ‘follow the science,’ which we are confident will lead to a change in marijuana’s status federally. The rescheduling process under the previous administration was unnecessarily protracted and fraught by allegations of malfeasance within DEA and we look forward to your renewed leadership to expedite this process and fulfill President Trump’s campaign promise to ‘unlock the medical uses of marijuana to a Schedule III drug’ and ultimately ‘implement smart regulations, while providing access for adults, to safe, tested product.’
“As such, we strongly encourage your office to continue advancing the cannabis rescheduling process in a timely and transparent manner. The recent recommendation by the Department of Health and Human Services to reclassify cannabis to Schedule III is grounded in the scientific, medical, and legal standards required by 21 U.S.C. § 811. Rescheduling would help eliminate unnecessary barriers to research, reduce burdens on legitimate businesses operating under state law, and bring federal policy more in line with overwhelming public opinion and decades of state-level reform.
“As DEA considers next steps, we respectfully urge your administration to recognize the importance of collaboration with stakeholders who can offer real-world insights into the public health, enforcement, and operational impacts of federal cannabis policy. NCIA and our members welcome any opportunity to be constructive partners in that effort.” – Aaron Smith
Kyle Sherman, Founder & CEO of Flowhub
“We’re watching the appointment of DEA Administrator Terrence Cole closely. While his background overseeing Virginia’s [Public Safety and Homeland Security] may seem encouraging, questions remain about the political motivations behind his selection. President Trump made clear just last week that this was a Governor Glenn Youngkin-backed appointment and publicly stated he would hold Youngkin accountable if Cole does not deliver. Youngkin, notably, has not been a supporter of the cannabis industry.
“Fortunately, Executive Order 14215, issued by President Trump in February 2025, ensures accountability at the federal level. Section 7 of that order explicitly prohibits agencies and their employees from issuing legal guidance or interpretations that deviate from those of the President and Attorney General. This safeguard exists to prevent political freelancing and keep federal policy aligned with the administration’s commitments.
“If Administrator Cole honors this Executive Order, the will of the public, the President’s promise to unlock safe access to medical cannabis through the reclassification of cannabis to a Schedule III drug, and his own promise to ‘listen to the experts’ and ‘follow the science’ as he testified during his nomination hearing, we’re hopeful he can be an agent of long overdue reform. But we’ll be watching closely.” – Kyle Sherman
Anthony Coniglio, CEO of NewLake Capital Partners
“The conversation around cannabis policy is again clouded by speculation. What we know is limited—but meaningful. Mr. Cole has said cannabis rescheduling will be ‘one of [his] first priorities,’ and that he will rely on science, expert consultation and the framework of the Controlled Substances Act to guide his decision.
“That’s not a political promise—it’s a procedural one. And in today’s regulatory climate, that matters.
“More telling is what Mr. Cole has made unequivocally clear: His focus will be on dismantling fentanyl networks and transnational criminal organizations. That aligns with the DEA’s 2025 National Drug Threat Assessment, which notably downplays cannabis and instead emphasizes synthetic drugs and the organized crime groups behind them. In that context, rescheduling cannabis isn’t just a policy adjustment—it’s a way for the DEA to better distinguish between bad actors and law-abiding, compliance-driven operators.
“Whether Mr. Cole will be a steward of regulatory modernization or a placeholder for the status quo remains to be seen. But the next 100 days offer a chance to turn a long-overdue page. If he leads with science and enforcement clarity—not outdated fears—this could be the start of a smarter, more modern drug policy.” –Anthony Coniglio
Terry Mendez, CEO of Safe Harbor Financial
“The Senate’s advancement of Terrance Cole’s nomination as DEA Administrator is a consequential development for the cannabis industry. With the rescheduling of cannabis under federal law stalled, the incoming DEA leadership will play a defining role in whether that reform moves forward—or remains mired in uncertainty.
“While we welcome Terry Cole’s stated commitment to reviewing the rescheduling proposal, the industry needs more than vague assurances. We need regulatory clarity, fairness, and above all, urgency. The decisions ahead will directly impact the viability of thousands of licensed cannabis operators and the broader financial infrastructure supporting them.
“However, even in the most optimistic scenario where cannabis is rescheduled from Schedule I to Schedule III, we must be clear-eyed about the limitations of that change. Rescheduling does not equate to legalization. It will not eliminate the burdensome compliance regimes that currently deter most large financial institutions from entering the market. Anti-Money Laundering and Bank Secrecy Act requirements will still apply, and the cannabis industry will remain federally criminalized in practice—if not in label.
“Contrary to popular belief, banking services for cannabis businesses are not unavailable today—but they are fragmented, costly, and carried disproportionately by smaller, specialized institutions like Safe Harbor. Rescheduling might offer incremental improvements, but absent updated FinCEN guidance and comprehensive congressional action like the SAFER Banking Act, the financial exclusion of cannabis operators will continue.
“This is a moment to double down on the push for safe banking, tax equity and transparent regulatory treatment. At Safe Harbor, we are committed to ensuring that cannabis businesses—large and small—have access to the financial tools they need to thrive. We urge the new DEA leadership to move swiftly, and Congress to act decisively, so this industry can finally be treated as what it is: legal, regulated, and essential to communities across America.” -Terry Mendez
The Wisdom of Oz: Green Grass, White Powder & Black Sabbath
by Chris Simunek
When you look back at the history of rock’n’roll, it is almost exclusively populated by people from two categories:
Those Who Got Fucked Up, and
Those Who Got Really Fucked Up.
For the latter part of the ’70s and all of the ’80s, Ozzy Osbourne was the Chairman of the Board for category number two. I learned of his legend the way most kids my age did—from pimple-faced geeks in denim jackets with their favorite album painted on the back. The story was always told with the appropriate reverence: He invented heavy metal, he drank a lot, he did a lot of drugs, made some great albums, was kicked out of Black Sabbath for being a loser and then he went solo, bit the head off a bird, bit the head off a bat, pissed on the Alamo, had a guitarist that died in a freak plane crash, went through a period where he looked and dressed a little like Liz Tay lor, and now he is sober and quite successful, albeit a bit shell-shocked.
On the heels of his successful Ozzfest tour, a traveling roadshow that has packaged the likes of Marilyn Manson, Tool, Type-0 Negative and Pantera, Ozzy stunned his fans with the announcement of his reunion with the other members of the original Black Sabbath lineup: guitarist Tony Iommi, bassist Geezer Butler and drummer Bill Ward. It’s something they’d been threatening to do for a decade, but the authentic Sabbath hadn’t played together (aside from a Live Aid appearance) since 1979. On December 5, 1997, they played in their hometown of Birmingham, England, a city of industry that makes Pittsburgh look like Paris, and recorded the show for their new live double-disc set, Reunion.
THE FOLLOWING INTERVIEW GOES TO “II”
Ozzy and Tony Iommi were in New York recently for a Letterman appearance and a meet-and-greet at the new Virgin Megastore in Union Square. When their people contacted HIGH TIMES about a possible interview, I thought it was a prank. I imagined some high school enemy of mine at the other end of the line— “Yeah man, Ozzy wants to hang out and do bong hits with you guys and then Alice Cooper’s gonna drop by with a couple peyote buttons…” Verifying my sources, I found it was true, Ozzy did have something to say to his bonghitting brethren, and was waiting for us in a suite at the St. Regis. Not wanting to undertake such an important mission alone, I invited Rob Braswell, HIGH TIMES’ production director/token metalhead, to join me. What Ozzy and Tony had to say to us we weren’t sure, but we weren’t going to pass up a chance to sit and giggle sycophantically at the feet of our gods.
We arrived early and had a few Berliner weissbiers at the Old King Cole bar to calm our nerves. As we discussed what questions we should ask our favorite air-guitar jamming partners, we both agreed this wasn’t a music interview. If you want to know what Ozzy thinks of the new album or where Tony nicked the riff to “Iron Man,” go read Guitar Player. We wanted tales of rock n roll debauchery, nothing more, nothing less. Ozzy’s people called the bar and informed us that the King of Doom was ready to see us. in the lobby, we were met by a publicist who told us that Ozzy was sick of talking about his indiscretions at American national landmarks and his past cruelties to the animal kingdom. It was implied that a good interviewer might want to steer clear of such subjects.
“Don’t worry,” I told her. ”I just want to talk about drugs.”
Ozzy and Tony were finishing up a previous interview when we walked into their suite. They were both dressed in classic black with large crosses dangling from their necks, sunglasses covering their eyes.
“Are you rolling yet?” Ozzy cracked as we entered.
When you meet Ozzy, it’s kind of like shaking the hand of a man who just came out of a 30-year panic attack. His hands tremble, his voice stutters, but imagine how you’d feel if you’d spent over a quarter-century in a drunken stupor, screaming your ass off in front of a wall of deafening amplifiers, tweaked on enough central-nervous-system stimulants to jump-start Walt Disney’s cryogenically frozen heart. Having heard that Ozzy was completely sober, I asked him if his rolling remark was just a joke.
“Why, you got any?” he inquired.
“Of course,” I said. “You think I’m going to come to this interview emptyhanded?”
“Is there any grown in New York?” he asked.
“Yeah, sure,” I said.
“What I used to do was nip every other leaf so it would grow out instead of up.”
I smiled. Ozzy had given us a genuine grow tip.
“What did you do?” I asked. “Grow it outdoors?”
“Yeah,” Ozzy said with a grin. “But then I got paranoid.”
The word hung there, begging a response.
“Yeah… to coin a phrase. So I’ve got to ask you about Sweet Leaf. Where did that come from?”
“Well, what do you think?” Ozzy laughed. “We used to smoke pounds of the shit, man. We used to buy it by the fuckin’ sackful. We used to be so fucked up all the time. Wake up in the morning, start the day with a spliff and go to bed with it. Yeah, it started to get… I started to get the heebee-jeebees. I was mixing all kinds of other chemicals. Booze, coke, pills…”
“Do you see a difference between pot and other chemicals?”
“Absolutely,” he said, waving his cigarette. “This, for instance, tobacco. I couldn’t smoke as many joints a day as I can this fuckin’ stuff. Gotta legalize pot. I’m all for the legalization of pot, decriminalize it. I don’t smoke it myself, but if anybody wants to smoke it, fine. I got busted for it. We all did.”
“Speaking of busts, what was it like for Black Sabbath to go through Customs in the ’70s?”
“Pretty scary.”
“Did you guys ever have to drop trou?”
“Oh yeah. I remember one time we went from Detroit to Canada through the tunnel. I grabbed one of the guys and asked him, ‘Have we done all the drugs?’ Then I go through my bags and empty them again and, remember them pipes you could get with a fish pump? You got like a fish-tank pump and all these wires and you put the pot in and you just suck on the pipe. They found that.” Ozzy hit his cigarette and chuckled. “Big rubber gloves, the whole nine yards. For fuckin’ smoking pot, man.”
“Do you get more paranoid in the States?”
“I just get paranoid,” he said. “When I do coke I’m like Mr. Paranoia. I’m fucking scared shitless. When you combine it with Demerol and opiates you get real fucked up, you know? You think to get normal, you have to get high. Anything in moderation, but with cocaine I couldn’t.”
“It makes for good VHi documentaries though,” I commented. “You guys in the ’70s had a rep for taking the most amount of time to record records.”
“We were fucked up!” Ozzy laughed at the obvious.
“Which record took the longest?”
“Oh, I don’t know,” Tony answered, not as impressed by Sabbath’s more dubious accomplishments as I was.
“We went to Canada one time, uh…” Ozzy looked at Tony to help him pull the memory out.
“Never Say Die.”
“Never Say Die took fuckin’ forever,” Ozzy said, and the two of them giggled like kids remembering a particularly naughty Halloween prank. “We got this guy coming around giving us bags of cocaine every fuckin’ Wednesday and we’d be like—” Ozzy clenched his face like a coke-freak frozen in action.
“Oh yeah,” Tony said. “When we started out the albums were quick and then…” He shrugged his shoulders, as if there was nothing that could be done about it now.
“With coke,” I wondered, “wouldn’t you record the album fast?”
“You’d do it and then you’d forget what you were doing!” Ozzy said laughing. “We couldn’t turn the fucking tape machine on! We’d turn like pause’ on instead of play/record,’ you know. We’d be playing for fuckin’ twenty-four hours.”
“These neat little bags,” Tony said, reminiscing, “Just chop us another line out! Get another can of beer out the fridge! Roll another joint!” Ozzy shouted. “We used to smoke blocks of hash. Big fuckin’… we used to buy hash by the pound.”
“And coke,” said Tony. “We used to buy these sealed bottles of coke.”
“Government-sealed,” Ozzy added. “We rented this house in Bel Air and we just had these fucking packages up to here—” With his hands Ozzy indicated a pile about the size of a Volkswagen. “It would come in like big gallon-bottles with a spoon on it, covered with a seal of wax. This coke was the best coke that I’ve ever had. I’m lying by the pool one day and I met this guy and I ask him You want to do some coke?’ He goes, No no no.’ I’m whacking this stuff up my nose, it’s a brilliant sunny day, and this guy’s sitting there with one of those reflectors under his chin getting a suntan. I say, What do you do?’ He says, I work for the government.’ Uh… what do you do with the government?’ I work for the drug squad.’ I sez, You’re fucking joking. He shows me his badge. I fuckin’ flipped. I was fuckin’—” Ozzy slammed his fist in his chest like a raging heartbeat. “Flames were coming out of my fingers, man. He says, Oh you’re all right, I’m the guy that got you the coke.’
“We all got fucked up but me and Bill went fuckin’ a little bit further,” Ozzy continued. “Bill ended up in a psychiatric fuckin place. Bill’s antidrug, antidrink, antieverything now. He don’t mince his fucking words either, you know.
With the coke and all these chemicals. 1 got a chemical imbalance in my brain. I’d become really shaky. I have to take Prozac and various medications just to stabilize me.”
“So you never drink, or every once in a while you’ll have something?”
“I don’t drink right now’. Every once in a while is like… I’ve done OK so far, you know’.
I’m not going to say Til never drink again.’ I don’t know. When I’m doing a show’ and I can smell that wonger out in the front, it does tempt me. One thing about the cocaine, though. It used to isolate you and you used to stay in your room paranoid. You buy a bag of white powder and the paranoia soon follows.”
“I’ll never do it again,” said Tony, remembering a promise he once made.
“And when you hear those birds going in the morning tweet-tweet you want to get a fucking machine gun and shoot every bird in sight.
When the day breaks it’s horrible. And what do you do when you wake up? Snnnnnnmmmmfff. Like a fiend, you know.”
“Why is it that so many rock stars crack up?” I asked. “Isn’t it supposed to be the best job in the world?”
“What other job can you imagine where the more fucked up you turn up, the better people think you’re gonna be? Oh fuckin’ Tony’s stoned or Ozzy’s stoned or Bill’s stoned… it’s going to be good fun tonight.’ Too much of anything, eventually you pay a price. If you play now, you pay later, I don’t give a fuck what it is.”
“Is it rough to be sober these days?” I asked, sensing a bit of regret in his voice.
“It sucks,” he replied bluntly. “I don’t like being sober, but say you chopped some lines, I’d go, ’Yeah, I’ll go for it.’ By twelve o’clock I’d be hanging off the fucking building screaming with a bottle of vodka in my hand. Once I start I can’t fucking stop. I gotta go all the way, you know.”
“So what do you do now to fill the gap?”
“Play with my dick,” Ozzy answered with a laugh. “In the ’70s there was a big period of time when I used to drink cheap wine and do ludes. I’d be like fucking jelly and the audience would be like a pond, a fucking oil slick. They were sweaty fuckin’ downed-out fuckin’…” Ozzy trailed off, as if he could still see that placid sea and then asked, “Did you ever try the original Quaaludes?”
The cooler half of Black Sabbath trained their eyes on me and for a moment I felt like a pink, newborn fetus. “No,” I answered with shame. “That’s a little bit before my time.”
“They were fucking wonderful, weren’t they?” Ozzy said and then looked to Tony for confirmation. “I could still get them,” Ozzy offered. “I know somebody who froze ten thousand.”
“Froze them?” I pictured a skinny hipster with sunken cheeks stocking up on 714s so that when the world’s methaqualone supply ran out, he could rise from his bunker and be the Lord of the Lucies.
I was running out of questions and would have to wing a few.
“We were wondering like…” I combed my beery skull for a relevant topic. “Well, since Meatloaf came out with Bat Out of Hell II and Frampton came out with Frampton Comes Alive II, would you ever come out with Volume IV, II?”
“No,” Tony answered as if I should know an artist of his caliber doesn’t repeat himself like that.
“I don’t think so, no,” Ozzy said, pondering the question before a grin split across his face and he let out another tremolo laugh. ” Volume IVII, yeah. Volume IV1/2 * 2… he-he-he.
“We had a question about like, uh… heavymetal fashion in the ’80s.”
“Oh, don’t,” Ozzy started. It was obviously a sore subject.
“What was up with that?”
“I look back at some of those things and I was drinking an enormous amount of booze. Every day I would drink four bottles of Hennessy, a case of Budweiser and as much fucking dope as I could get down my fucking face. As much as I could. I was overdosing on a daily basis.” Ozzy laughed again at the thought of it. Unlike other sober-rockers, he still gets a kick out of his past.
“That’s where the funny clothes came from?” I asked.
“I think that’s where the funny everything came from,” he answered. “We all thought we looked cool. Now we look at ourselves—gay wasn’t even the word. Gay people used to come to us and say, What are you fucking doing, man?’ ” Ozzy pondered for a moment and said, “It’s all part of the crazy world of rock’n’roll.”
I made the mistake of mentioning the time Ozzy put on a dress and redecorated the Alamo and he visibly cringed. It was like asking Achilles to repeat the story about the time he fucked up his heel. He was somewhat appeased when I informed him that this incident was now a highlight of the Alamo tour. At first he didn’t believe me, but I swore to him that a Texan friend had just seen it.
“They should put it in the Guinness Book of World Records.” offered Tony.
“Your own indelible mark upon American history,” I said and a proud, impish smile spread across Ozzy’s face. Our time was running out, so we asked Ozzy to autograph a few records. I handed him my beaten copy of Paranoid. With a quivery hand Ozzy scrawled “Get Stoned” across the gatefold and then signed his name. It was advice from an expert.
Back down at the Old King Cole, Rob and I felt invigorated, like we’d just been to the Rock’n’Roll Doctor and he’d given us a shot of Vitamin Cool.
“He was just like I imagined,” Rob cooed.
“Yeah,” I said, my eyes full of butterflies. That a guy could go through what Ozzy did and still be on top was more than luck, it was damn close to a miracle. When the going got tough, he dressed up in women’s clothing and pissed on national landmarks.
I decided from that point on to try and be more like Ozzy.
He has a message for people like me: If you want a yellow brick road to follow, you have to pause sometimes and paint the stones yourself.
Several reforms to North Dakota’s medical cannabis law are set to take effect August 1, including the sale of low-dose THC edibles and extended timeframes for the validity of medical cannabis cards, the North Dakota Monitor reports.
Edibles now allowed under the medical cannabis program may contain no more than 5 milligrams of THC and no more than 50 milligrams per package. The products can be in the form of a lozenge or a square shape; other foods or beverages are not allowed.
Jake Mittelsteadt, director of retail operations for Pure Dakota Health, told the Monitor that allowing edibles could be a game changer for patients.
“Since day one of this program, the amount of people that joined the program, that come to the state, everybody, especially in the older demographics, their priorities have always been gummies and edibles.” — Mittelsteadt to the Monitor
Under the reforms, patients will also be able to qualify for the program via telehalth rather than just using telehealth services to renew their medical cannabis cards. Medical cannabis cards are also now valid for two years instead of one.
TG joined Ganjapreneur in 2014 as a news writer and began hosting the Ganjapreneur podcast in 2016. He is based in upstate New York, where he also teaches media studies at a local university.
More by TG Branfalt